Theracryf (TCF) Competitors GBX 0.54 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors TCF vs. SPO, NWT, IX, TREE, STL, HWC, AGM, FCRM, SFE, and ABTXShould you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Sportech (SPO), Newmark Security (NWT), i(x) Net Zero (IX), Cambium Global Timberland (TREE), Stilo International (STL), Highway Capital (HWC), Applied Graphene Materials (AGM), Fulcrum Utility Services (FCRM), Safestyle UK (SFE), and ABTX.L (ABTX). These companies are all part of the "banking" industry. Theracryf vs. Sportech Newmark Security i(x) Net Zero Cambium Global Timberland Stilo International Highway Capital Applied Graphene Materials Fulcrum Utility Services Safestyle UK ABTX.L Sportech (LON:SPO) and Theracryf (LON:TCF) are both small-cap consumer cyclical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Does the MarketBeat Community favor SPO or TCF? Sportech received 234 more outperform votes than Theracryf when rated by MarketBeat users. CompanyUnderperformOutperformSportechOutperform Votes23479.05% Underperform Votes6220.95% TheracryfN/AN/A Do insiders & institutionals believe in SPO or TCF? 61.3% of Sportech shares are held by institutional investors. Comparatively, 37.0% of Theracryf shares are held by institutional investors. 31.4% of Sportech shares are held by company insiders. Comparatively, 42.9% of Theracryf shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, SPO or TCF? Sportech has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Theracryf has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Is SPO or TCF more profitable? Sportech has a net margin of 2.47% compared to Theracryf's net margin of 0.00%. Sportech's return on equity of -3.95% beat Theracryf's return on equity.Company Net Margins Return on Equity Return on Assets Sportech2.47% -3.95% 0.31% Theracryf N/A -81.67%-48.26% Does the media refer more to SPO or TCF? In the previous week, Sportech had 1 more articles in the media than Theracryf. MarketBeat recorded 1 mentions for Sportech and 0 mentions for Theracryf. Sportech's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score. Company Overall Sentiment Sportech Neutral Theracryf Neutral Which has preferable earnings & valuation, SPO or TCF? Sportech has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Sportech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSportech£26.98M0.00-£1.01M-£0.05N/ATheracryfN/AN/A-£3.14M-£0.01-53.75 SummarySportech beats Theracryf on 8 of the 12 factors compared between the two stocks. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Theracryf News Delivered to You Automatically Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCF vs. The Competition Export to ExcelMetricTheracryfBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.30M£149.53M£5.23B£1.80BDividend YieldN/A3.64%5.54%6.69%P/E Ratio-53.75151.5393.141,781.77Price / SalesN/A18,535.281,239.27284,241.44Price / CashN/A12.1141.4323.85Price / Book0.548.137.232.93Net Income-£3.14M-£20.18M£119.93M£183.68M7 Day Performance-2.27%0.53%2.14%-0.04%1 Month Performance-15.88%8.58%-2.23%-0.46%1 Year PerformanceN/A30.52%32.63%25.05% Theracryf Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCFTheracryfN/AGBX 0.54flatN/AN/A£2.30MN/A-53.7510Gap UpHigh Trading VolumeSPOSportechN/AGBX 84+12.1%N/AN/A£8.40M£26.98M-1,680.00217,000News CoverageGap UpHigh Trading VolumeNWTNewmark SecurityN/AGBX 80flatN/A+58.4%£7.50M£22.28M8,000.00102Positive NewsGap DownIXi(x) Net ZeroN/AN/AN/AN/A£6.99M£80.05M14.8132,200Gap UpHigh Trading VolumeTREECambium Global TimberlandN/AGBX 6.75-56.2%N/A+0.0%£4.98M£4.57B11.271,250Gap DownHigh Trading VolumeSTLStilo InternationalN/AGBX 3+233.3%N/A+0.0%£3.42M£1.42M30.001,907Gap UpHWCHighway CapitalN/AGBX 15.50+∞N/A+0.0%£1.78MN/A0.003,630Gap UpAGMApplied Graphene MaterialsN/AGBX 1-81.0%N/A+0.0%£643,000.00£127,000.00-20.00160Gap DownFCRMFulcrum Utility ServicesN/AN/AN/AN/A£599,000.00£50.55M-3.0050Gap DownSFESafestyle UKN/AN/AN/AN/A£444,000.00£150.18M-4.5718,500ABTXABTX.LN/AN/AN/AN/A£0.00N/A0.00590High Trading Volume Related Companies and Tools Related Companies SPO Competitors NWT Competitors IX Competitors TREE Competitors STL Competitors HWC Competitors AGM Competitors FCRM Competitors SFE Competitors ABTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:TCF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theracryf Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Theracryf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
